NEW YORK, Sept 27 – Chip-maker Nanogen (Nasdaq: NGEN) said Wednesday that it has created Nanogen Europe to extend its marketing and sales efforts throughout the continent.
San Diego-based Nanogen, which only recently began marketing its NanoChip system to scientists and genomics laboratories for single-nucleotide polymorphism scoring, made its first commercial sale to French life sciences company Aventis (NYSE: AVE) in June. And a week ago it sold the system to German food additives company SKW Nature Products.
Howard Birndorf, chairman and CEO of Nanogen said in a statement that the new unit was created because he sees Europe as “a potentially important market.”
Roderik van den Bogaard, formerly of Molecular Dynamics and Spectra Physics, has been named managing director of the company’s wholly owned subsidiary based in Helmond, the Netherlands.
Nanogen was up 1/16, or 0.33 percent, at 18 3/4 in afternoon trading.